Covid-19 situation
Document
The effects of the Covid-19 outbreak are escalating daily and is first and foremost a human tragedy, affecting hundreds of thousands of people.
This statement reflects our perspective and the possible impact on our ability to supply as of March 16, 2020. TSS is closely monitoring developments around the novel coronavirus outbreak and we will continue to update you on the situation as it pertains to our business.
What is on this page?
Click to jump to a specific section below.
At present we have no supply disruption and the company operates without any impact on daily business. We have material in stock to continue to maintain delivery reliability.
Niclas Ohlsson, CEO TSS
We are taking the situation seriously and are focusing our efforts in minimizing the risk on future impact on business operations. We take several actions to support the national and international efforts to even out the spread over time and protect risk groups in the community. Our contingency plans and activities are centered around the following areas:
Cross-functional response team
- The management team meet daily to assess the situation and take measures as deemed necessary based on the latest published information.
- We follow the guidelines of leading global and local governmental, health and work environment authorities.
Protecting employees
- We currently have no employees known to be affected by the virus.
- Employees who can perform their work duties from home are encouraged to do so.
- Meetings are primarily held as video conference, travel is restricted.
- New safety measurements by anyone receiving goods from external sources.
- TSS premises have been equipped with additional disinfectant supplies and routines for use, in addition to daily extra cleaning and disinfection.
.jpeg)
Supply chain integrity
- TSS is operating with a structured Supply Chain Risk Management process and are prepared to manage emergency situations as best as possible.
- We are closely monitoring our supplier’s abilities to supply components for our production. We currently have no delays or component shortage.
- We demand and review contingency plans from our critical suppliers.
- We have currently no disruption in delivering to planned destinations.
Stay close to customers
- We more often than ordinary ask for a forecast update from customer. This is simply to ensure that we will be able to support any fluctuation in supply needs and ensure business continuity.
Financial stability
- TSS is financially stable, and we currently don’t foresee any major disruption to our business due to the COVID-19 outbreak.
Finally, we are humble to the fact that we are currently part of one of the most important functions in the world. Securing the supply chain of pharmaceuticals, vaccines and other medical supplies and ensuring its integrity is of highest importance in situations like the one we are in now.
Stay safe!
You may also be interested in
Automation is making temperature excursion management simpler and more efficient for clinical sites
Are healthcare professionals working at clinical sites across the world satisfied? It might seem like a strange question to ask, but the way we feel can impact our professional performance in important ways. Perhaps the question is not how satisfied Clinical Operations professionals are, but whether they feel their performance is impacted by lots of time-consuming manual processes that could benefit from automation? Are these processes hampering clinical trial performance?
Read moreDownload Whitepaper
Balancing Cost and Quality in the Pharmaceutical Supply Chain: A Quick Guide
In the life-science industry, finding the right balance between cost and quality in the supply chain is crucial. This balance ensures that pharma companies remain financially healthy while delivering safe and effective products to patients. However, achieving this balance can be challenging due to the complexities of quality management, procurement, and temperature control.
Read moreDownload Whitepaper
We are back at Clinical Trial Supply East Coast
We are excited to join the 20th Anniversary edition of Clinical Trial Supply East Coast on the 19th and 20th October 2022 in the Sheraton King of Prussia. The conference covers all things CTS from reducing timelines and streamlining processes to handling clinical supplies in a decentralized trial world. Along speakers from Pfizer, Merck, Janssen and many more we will present how digitalization of temperature processes can improve business outcomes in clinical trials.
Read moreDownload WhitepaperYou may also be interested in
How to Scale Up Your Clinical Trials
Pharmaceutical companies are under pressure to bring new drugs to market quickly. This urgency is driven by the needs of patients, requirements from authorities, and investors. Clinical trials are a crucial part of this process, but they can be delayed by manual processes.
Read more
Sustainable Temperature Management: A Key to Greener Clinical Trials
As the global healthcare industry focuses more on sustainability, temperature management in clinical trials is becoming more important. Research organizations and clinical trial sponsors are starting to see that making clinical trial processes more sustainable is not only good for the environment but also improves efficiency and cuts costs.
Read more